This inventor holds 6 USPTO granted patents. Top assignees: Beijing University of Technology, Metabolic Pharmaceuticals Limited, International Diabetes Institute. Active years: 1999-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Vermont South, AU (2000)
- Kew, AU (1999 - 2007)
Company Filing History:
3 out of 389 
3 out of 3 
1 out of 2 Years Active: 1999-2007
Title: Frank Man-Woon Ng: Innovator in Hypoglycaemic Peptides and Obesity Control
Introduction
Frank Man-Woon Ng is a notable inventor based in Kew, Australia. He has made significant contributions to the fields of biochemistry and metabolic health, holding a total of 6 patents. His work primarily focuses on the development of peptides that regulate blood glucose levels and methods for controlling obesity.
Latest Patents
Ng's latest patents include innovative solutions for managing Type 2 diabetes and obesity. One of his key inventions is a peptide formula designed to regulate in vivo blood glucose levels in humans and other mammals. This peptide, characterized by the formula (Xaa)-Xaa-His-Thr-Asp-(Xaa), has shown promise in treating Type 2 diabetes. The peptide can be isolated from human urine or chemically synthesized, with specific examples including Gly-His-Thr-Asp and Val-His-Thr-Asp.
Another significant patent involves food and beverage products aimed at obesity control. This invention utilizes transgenic plants that contain a nucleic acid molecule encoding a C-terminal growth hormone fragment. This fragment has the ability to modulate lipid metabolism, making it a valuable tool in the production of fermented food or beverage products.
Career Highlights
Throughout his career, Frank Man-Woon Ng has worked with esteemed institutions such as Beijing University of Technology and Metabolic Pharmaceuticals Limited. His research has contributed to advancements in metabolic health and the development of innovative therapeutic solutions.
Collaborations
Ng has collaborated with notable colleagues, including Woei-Jia Jiang and Siria Helen-Anna Natera. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Frank Man-Woon Ng is a pioneering inventor whose work in hypoglycaemic peptides and obesity control has the potential to transform health outcomes for many individuals. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and improving public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile